New research published in Neuro-Oncology gives a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes. 

A team of scientists from Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center and the University of Texas MD Cancer Center uncovered a protein, TRNAU1AP, that plays an essential role in helping glioblastoma cells survive and multiply, along with a potential pathway to make these cancer cells more vulnerable to treatment. 

A study identifies three characteristics that help determine when conspiracy beliefs are most likely to shape real-world behavior: how certain people are that the belief is true, how personally important they consider it, and whether they see it as “actionable” – useful for deciding what to do.